Everybody needs money. That's why they call it money.

From full global headquarters, this is Motley Fool Money. It's the Motley Fool Money

radio show. I'm Chris Ellin joining me in studio this week for Million Dollar Portfolio

Jason Moser and for Million Dollar Portfolio and Supernova Matt Argersinger and Simon Erickson

Good to see you as always, gentlemen. We have got the latest headlines from Wall Street.

We will head to Austin, Texas for a report from South by Southwest and as always we'll

give you an inside look at the stocks on our radar. But we begin this week in the healthcare

industry shares of valiant pharmaceuticals down 60% after the company said it would miss

a deadline to file its annual report. CEO Mike Pearson sent a memo to employees assuring

them that the company was not on the verge of bankruptcy. I guess it just kind of looks

that way, huh Matt? Chris, it was gosh, three weeks ago, I think we were on the show and

we said, you know, where there's smoke, there's fire. Well, it turns out there's actually

napalm. It comes with nine pharmaceuticals, you know, not to be dramatic. But this is a

company with a lot of problems right now. So delaying the 10K filing, companies do that

a lot. But usually for the wrong reasons, it's usually there's an accounting irregularity

and it turns out they probably have several. And what that does, more worrisome is that

that's going to trigger possibly from their bank lenders accelerated debt payments. Now

this is a company with $30 billion in debt, three times the market cap right now, a Sri

ankan market cap. And you have the CEO who's potentially leaving, you have a shifting

back towards what they say is going to be organic organic growth versus acquisitions,

which was what they're known for. There's so many red flags. I don't even know where

to start with this one. And if you're an investor who's looking at this company and thinking,

...